Zhejiang Jiuzhou Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GEFITINIB, with a corresponding US DMF Number 30518.
Remarkably, this DMF maintains an Active status since its submission on April 28, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 28, 2016, and payment made on June 15, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II